03 July, 2025 in Uncategorized Pantherna Therapeutics Further Expands Global IP Portfolio with New Patent Grant in Canada
04 June, 2025 in Uncategorized Pantherna Therapeutics Expands IP Portfolio with New Patent Grant in South Korea
16 April, 2025 in Uncategorized Pantherna Therapeutics Secures Japanese Patent for PTXmRNA® Technology
25 October, 2024 in Uncategorized Pantherna Therapeutics and TQ Therapeutics announce research collaboration to advance ultra-short Cell and Gene Therapy (CGT) process leveraging LNP technology
26 September, 2024 in Uncategorized Pantherna Announces Research collaboration with Bayer to Advance LNP Technology for Beyond Liver mRNA Therapy
01 August, 2024 in Uncategorized BioSpring and Pantherna agree on strategic cooperation in the field of genome editing
05 April, 2024 in Uncategorized Pantherna and WACKER Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals
25 October, 2023 in Allgemein New article alert: “Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage”.
